By Russ Ward (@russcward)
Imitation is the best form of flattery. You’ve heard that cliche, right? We’re going to talk about that a little bit today. But it’s actually about more than imitation – we’re going to talk about assimilation, and how you need to be doing it.
When the word [...]
Tags:assimilation·drug·Facebook·HTML·HTML5·research·science·Social network·technology·Twitter
By Guy Mastrion (@gmastrion)
Hey, did you see the trailer for that wild new science fiction movie? The one where robots are the size of cells and you can swallow them, and they’ll go to work inside you?
Well, that wasn’t actually a movie trailer – but it might have been your evening news…what’s it all about?
Nanotechnology [...]
Tags:Cancer·health reform·nanomedicine·nanoparticle·NIH·oncology·research·technology
By Russ Ward (@russcward)
Contining our week on New Jobs in Pharma, we’ll talk today about government job opportunities.
When you talk about government jobs in pharma, most people might assume that you’re talking about working for the Food and Drug Administration. Well – the best answer there is “maybe”. First, because [...]
By Marty Hardin (@mjhardin)
In Gilbert Ryle’s 1949 book The Concept of Mind, he introduced the phrase which titles this blog entry. He is arguing against Descartes’ concept of mind/body parallelism and the ambiguous point in which the two function in conjunction with one another. Think daydreaming while running on the treadmill as opposed to deciding [...]
Tags:communication·Conferences·doctors·engagement·innovation·insight·marketing·Patients·Pharma·research
This week, Pixels & Pills is celebrating partnerships. Some are unexpected. Some haven’t happened yet, but need to. And some just plain make sense. Come along with us as we discuss the very principle that P&P is founded on.
By Jason Brandt (@Jasondmg3)
In our week on partnerships, we’re covering a variety of different kinds of collaborative [...]
Tags:academic institutions·biotech·branding·collaboration·communication·diagnostic·digital strategy·hospitals·partnerships·Pharma·research
By Russ Ward (@russcward)
The most recent McKinsey Quarterly offered a report called “The Road to Positive R&D Returns.” Essentially, it said that traditional small molecules are no longer a viable business plan for pharma companies, and that they can’t hang their hats on biologics either, because they’re running into many the same issues with development [...]
Tags:biologics·business·development·innovation·Pharmaceutical industry·research·technology
By Guy Mastrion
An article in a recent issue of WIRED cited statistics that the placebo effect is twice as strong as it used to be.
Is it really, I wondered? I guessed not. I guessed that there was a good reason for it. And I came up with a couple of possibilities.
First possibility. What if we [...]
Tags:brain-body relationship·Pharma·Pharmaceutical industry·research·Thought Leaders·Trends
